Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles–Rubella Supplementary Immunization Activity during the COVID-19 Pandemic
Vaccines · 07.03.2023 · 11 (3) · 608
DOI: 10.3390/vaccines11030608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 07.03.2023. Verfasst von Yangyupei Yang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, Gates Foundation, NIAID NIH HHS.
Abstract (Originalsprache)
Background
Measles–rubella supplementary immunization activities (MR-SIAs) are conducted to address inequalities in coverage and fill population immunity gaps when routine immunization services fail to reach all children with two doses of a measles-containing vaccine (MCV). We used data from a post-campaign coverage survey in Zambia to measure the proportion of measles zero-dose and under-immunized children who were reached by the 2020 MR-SIA and identified reasons associated with persistent inequalities following the MR-SIA.
Methods
Children between 9 and 59 months were enrolled in a nationally representative, cross-sectional, multistage stratified cluster survey in October 2021 to estimate vaccination coverage during the November 2020 MR-SIA. Vaccination status was determined by immunization card or through caregivers’ recall. MR-SIA coverage and the proportion of measles zero-dose and under-immunized children reached by MR-SIA were estimated. Log-binomial models were used to assess risk factors for missing the MR-SIA dose.
Results
Overall, 4640 children were enrolled in the nationwide coverage survey. Only 68.6% (95% CI: 66.7%, 70.6%) received MCV during the MR-SIA. The MR-SIA provided MCV1 to 4.2% (95% CI: 0.9%, 4.6%) and MCV2 to 6.3% (95% CI: 5.6%, 7.1%) of enrolled children, but 58.1% (95% CI: 59.8%, 62.8%) of children receiving the MR-SIA dose had received at least two prior MCV doses. Furthermore, 27.8% of measles zero-dose children were vaccinated through the MR-SIA. The MR-SIA reduced the proportion of measles zero-dose children from 15.1% (95% CI: 13.6%, 16.7%) to 10.9% (95% CI: 9.7%, 12.3%). Zero-dose and under-immunized children were more likely to miss MR-SIA doses (prevalence ratio (PR): 2.81; 95% CI: 1.80, 4.41 and 2.22; 95% CI: 1.21 and 4.07) compared to fully vaccinated children.
Conclusions
The MR-SIA reached more under-immunized children with MCV2 than measles zero-dose children with MCV1. However, improvement is needed to reach the remaining measles zero-dose children after SIA. One possible solution to address the inequalities in vaccination is to transition from nationwide non-selective SIAs to more targeted and selective strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA.
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21231, USA.
- Ministry of Health, Government of the Republic of Zambia, Lusaka 10101, Zambia.
- Zambia Statistics Agency, Lusaka 10101, Zambia.
- Zambia Country Office, World Health Organization, Lusaka 10101, Zambia.
- Department of Epidemiology, University of Georgia, Athens, GA 30602, USA.
ORCID-Profile: Natalya Kostandova, Andrea C Carcelen, Simon Mutembo
Förderung
- World Health Organization
- Gates Foundation
- NIAID NIH HHS
- JHPIEGO Zambia country office
- Macha Research Trust
- the Gavi the Vaccine Alliance through the Ministry of Health, Zambia
- Grand Challenges Explorations initiative
Zitieren
APA
Yang, Y., Kostandova, N., Mwansa, F. D., Nakazwe, C., Namukoko, H., Sakala, C., Bobo, P., Masumbu, P. K., Nachinga, B., Ngula, D., Carcelen, A. C., Prosperi, C., Winter, A. K., Moss, W. J., & Mutembo, S. (2023). Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles–Rubella Supplementary Immunization Activity during the COVID-19 Pandemic. Vaccines, 11(3), 608. https://doi.org/10.3390/vaccines11030608
Vancouver
Yang Y, Kostandova N, Mwansa FD, Nakazwe C, Namukoko H, Sakala C, et al. Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles–Rubella Supplementary Immunization Activity during the COVID-19 Pandemic. Vaccines. 2023;11(3):608. doi:10.3390/vaccines11030608
BibTeX
@article{Yang2023,
author = {Yang, Yangyupei and Kostandova, Natalya and Mwansa, Francis Dien and Nakazwe, Chola and Namukoko, Harriet and Sakala, Constance and Bobo, Patricia and Masumbu, Penelope Kalesha and Nachinga, Bertha and Ngula, David and Carcelen, Andrea C and Prosperi, Christine and Winter, Amy K and Moss, William J and Mutembo, Simon},
title = {Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles–Rubella Supplementary Immunization Activity during the COVID-19 Pandemic},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {3},
pages = {608},
doi = {10.3390/vaccines11030608}
}
EUVIMED